Ascorbic Acid Significantly Decreases Creatine Kinase Plasma Levels in an Animal Model of Statin/Fibrate-Induced Myopathy
Background. Myopathy is one of the side effects of lipid-lowering drugs, especially statins and particularly when combined with a fibrate. To diagnose myopathy and determine its severity, the plasma levels of three enzymes, creatine kinase (CK), aldolase, and lactate dehydrogenase (LDH), are routine...
Saved in:
| Main Authors: | Mohsen Zabihi, Fatemeh Askarian, Seyedhossein Hekmatimoghaddam, Mohammadreza Rashidi Nooshabadi, Mohammad Sajjad Zabihi, Seyed Ruhollah Mousavinasab |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2021-01-01
|
| Series: | Advances in Pharmacological and Pharmaceutical Sciences |
| Online Access: | http://dx.doi.org/10.1155/2021/5539595 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
STATINS AND MYOPATHY: MOLECULAR MECHANISMS
by: O. M. Drapkina, et al.
Published: (2015-12-01) -
MYOPATHY CAUSED BY THE INTERACTION OF COLCHICINE AND STATINS
by: A. S. Kazakov, et al.
Published: (2018-09-01) -
Comparing efficacy of fibrates and statins in isolated and combined hypertriglyceridemia and various types of oxidative metabolism
by: G. S. Mal’
Published: (2005-06-01) -
MYOPATHY AS A SIDE EFFECT OF STATIN THERAPY: MECHANISMS OF DEVELOPMENT AND PROSPECTS FOR TREATMENT
by: O. M. Drapkina, et al.
Published: (2015-09-01) -
APPLIED ASPECTS OF SLCO1B1 PHARMACOGENETIC TESTING FOR PREDICTING OF STATIN-INDUCED MYOPATHY AND PERSONALIZATION OF STATINS THERAPY
by: D. A. Sychev, et al.
Published: (2015-09-01)